UK SMEs can apply for a share of up to £10 million to work on solving healthcare challenges in a clinical setting or a relevant late stage environment. Apply now for a late stage award in the Biomedical Catalyst. Biomedical Catalyst supports the development of innovative healthcare products, technologies and processes.
There are 4 types of funding award: feasibility, primer, early stage and late stage.
Please see below a summary of the funding call:
Project size: From £200,000 to £4million
Project duration : 12 to 36 months (must start before 1 July 2019)
Deadline : 3 October 2018, Wednesday
UK SMEs can apply for a share of up to £5 million to work alone or with others on solving healthcare challenges in a model system. Apply now for a primer award in the Biomedical Catalyst. The primer award is running alongside the late stage award. Applications welcome from any sector or discipline.
Please see below a summary of the funding call:
Project size: From £200,000 to £1.5million
Project duration : 12 to 24 months (must start before 1 April 2019)
Deadline : 3 October 2018, Wednesday
Digital Health Technology Catalyst 2017 – Round 1. DEADLINE 11/10/17










Dr. Paul Whittington attends Technology and the SEND Reforms Roundtable in the House of Commons
Dr. Paul Whittington joins Bett 2026 DfE Assistive Technology Roundtable
BU Prof Jonathan Parker promoting social work in Malaysia
New interdisciplinary paper accepted for publication
Three NIHR Internships awarded at BU
Research highlighted at the UN in New York
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease